Literature DB >> 18243681

Setting targets for universal access to HIV prevention, treatment and care for injecting drug users (IDUs): towards consensus and improved guidance.

Martin C Donoghoe1, Annette Verster, Cyril Pervilhac, Paul Williams.   

Abstract

Scaling-up access to HIV/AIDS prevention, treatment and care for injecting drug users (IDUs) has been frustrated by the lack of a framework, indicators and agreed targets for interventions specifically targeting IDUs. Major progress in this regard has been achieved with the recent development of a joint Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users and related technical consultations. This guide provides technical guidance to countries on setting ambitious, but achievable national targets for scaling-up towards universal access (UA). The guide has been developed as a collaboration between the Joint United Nations Programme on HIV/AIDS (UNAIDS), the United Nations Office on Drugs and Drugs (UNODC), the World Health Organization (WHO) and with national and international expertise and builds on previous UNAIDS guidelines. The guide serves to provide more consistent methods of measuring and comparing countries' progress towards universal access and offers consensus as to which interventions should be included in a comprehensive package. It provides guidance on defining and estimating denominator populations and proposes a set of indicators to measure coverage, as well as indicative targets or benchmarks against which to measure progress towards UA. The guide moves on from a narrow focus on coverage that neglects other important aspects of access, namely availability and quality of interventions. Finally, the guide encourages country involvement in, and ownership of, what are sometimes perceived as politically motivated coverage targets. Technical consultations, with country experts using the guide to set national targets, suggested a tendency for targets to be proposed that are achievable but fall short of what is required to achieve universal access and have a real impact on HIV/AIDS epidemics. Consensus and improved guidance on achieving universal access needs to be supported by political will, good leadership and, in some countries, remedies to inadequacies in health systems.

Entities:  

Mesh:

Year:  2008        PMID: 18243681     DOI: 10.1016/j.drugpo.2007.12.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  19 in total

1.  Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Salaam Semaan
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

2.  The urgency of providing comprehensive and integrated treatment for substance abusers with HIV.

Authors:  Nora D Volkow; Julio Montaner
Journal:  Health Aff (Millwood)       Date:  2011-08       Impact factor: 6.301

3.  HERMITAGE--a randomized controlled trial to reduce sexually transmitted infections and HIV risk behaviors among HIV-infected Russian drinkers.

Authors:  Jeffrey H Samet; Anita Raj; Debbie M Cheng; Elena Blokhina; Carly Bridden; Christine E Chaisson; Alexander Y Walley; Tibor P Palfai; Emily K Quinn; Edwin Zvartau; Dmitry Lioznov; Evgeny Krupitsky
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

4.  Patterns of injection drug use cessation during an expansion of syringe exchange services in a Canadian setting.

Authors:  Dan Werb; Thomas Kerr; Jane Buxton; Jeannie Shoveller; Chris Richardson; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2013-05-01       Impact factor: 4.492

5.  Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009.

Authors:  Dita Broz; Huong Pham; Michael Spiller; Cyprian Wejnert; Binh Le; Alan Neaigus; Gabriela Paz-Bailey
Journal:  AIDS Behav       Date:  2014-04

6.  HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Lucia V Torian; Sara Beatice; Salaam Semaan; Samuel R Friedman
Journal:  Drug Alcohol Depend       Date:  2010-02-16       Impact factor: 4.492

7.  Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.

Authors:  Javier A Cepeda; Ksenia Eritsyan; Peter Vickerman; Alexandra Lyubimova; Marina Shegay; Veronika Odinokova; Leo Beletsky; Annick Borquez; Matthew Hickman; Chris Beyrer; Natasha K Martin
Journal:  Lancet HIV       Date:  2018-07-20       Impact factor: 12.767

8.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Authors:  Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

9.  Methadone maintenance therapy in Vietnam: an overview and scaling-up plan.

Authors:  Tam T M Nguyen; Long T Nguyen; Manh D Pham; Hoang H Vu; Kevin P Mulvey
Journal:  Adv Prev Med       Date:  2012-11-25

10.  Evaluation of a pilot medication-assisted therapy program in Kazakhstan: successes, challenges, and opportunities for scaleup.

Authors:  Azizbek A Boltaev; Anna P Deryabina; Almas Kusainov; Andrea A Howard
Journal:  Adv Prev Med       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.